MLN4924 was found to trigger epidermal growth factor receptor (EGFR) dimerization and activate EGFR downstream signaling pathways such as RAS/RAF/MEK/ERK and PI3K/AKT1/mTOR promoting tumor sphere formation and inducing wound healing in mouse models. The gene discussed is AKT1; the disease is neoplasm.